NCT06351371

Clinical Trial Information

Trial Number: NCT06351371 (ClinicalTrials.gov)

Disease Type:

Hematopoietic Neoplasm/Lymphoma - Miscellaneous
Hematopoietic Neoplasm/Myeloma - Myeloma
Miscellaneous Neoplasm - Solid Tumor

Trial Title:

MATCH Treatment Subprotocol K2: Phase 2 Study of Erdafitinib (JNJ-42756493) in Patients With Tumors With FGFR Mutations or Fusions

Study ID:

EAY131-K2

Images are available?:

No

Is this a NCI-MATCH Trial?:

Yes

Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security

U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov

NIH…Turning Discovery Into Health^®